Luven Diagnostic

Status

Past

Description

Update: ICO Failed, Returns will be issued.

Starting date

January 15th, 2018

Ending date

February 28th, 2018

Website

View Website

Whitepaper

View Whitepaper

Links
Features

The LUVEN technology allows to diagnose the disease at its early stages, thus, giving a chance to thousands of people to prevent its further development.
For more than 20 years the Ukrainian scientists have been developing a diagnostic method based on cyto-morphological and cyto-biophysical properties of the buccal epithelial cells. In 2004 at Fenix Cancer Research Center, they continued their research and, finally, came up and implemented an experimental method.
A new method of biomaterial analysis allowed to establish a cancer diagnosis at its early stages and to assess predisposition to cancer .A great success in this medical field opened a door to new possibilities, including cancer prevention and therapy.
The longstanding scientific research in this field culminated in development of The Luven diagnostic system.

Official Video
Whitelist
Yes
Token Sale Hard Cap
TBD
Token Sale Soft Cap
TBD
Token Symbol
LVN
Initial Token Price
1 ETH = 290 LVN
KYC
No
Core Team

Alexander Danilchenko
CEO

Nikolay Shchukin
Postgraduate Student of Chair for Biomedical Engineering

Aleksander Shchukin
Niclear physicist

Galina Shchukina
Geneticist & Cytologist

Grigory Evglevskiy
CTO

Alexander Kamensky
Principal Software Engineer

Yana Ivchenko
PR Manager

Lina Lisitsa
SMO/SMM Manager